Beijing pharma firms suspended over bribery
28 November 2007
Twenty-one pharmaceutical companies in Beijing received two-year suspensions as a result of being blacklisted in a new campaign launched by the city's health bureau, Beijing Times reported (in Chinese). Many companies in the sector agreed the crackdown will improve market order, though some of those listed argued the campaign was unfair as nearly every pharmaceutical firm commits bribery. "We have to [give bribes], otherwise we are cannot survive in this market," said Mr Ren, the owner of Beijing Fuji Pharmaceutical Instruments Company, one of the blacklisted companies.
Bookmark and Share:
Other Categories
Other news from 28 November 2007
Related Articles
- Industrial output growth slows
- WHO representative: No cover-up in EV71 cases
- China's GDP rises 10.6% in first quarter
- China revises 2007 GDP estimate up
- Consumer confidence slips in Q1
To receive the best China business news that the market has to offer,
subscribe to the China Economic Review.
subscribe to the China Economic Review.